Breast Cancer Genes and Patient Protection in an Era of Personalized Medicine
By Karuna Jaggar,
Huffington Post
| 03. 20. 2014
Genetic testing is often heralded as a cornerstone in an imminent and exciting new age of personalized medicine, in which our health care is customized based on our individual genetic profiles. But let's not get carried away by the fantasy and promise; progress has lagged while persistent medical, ethical and scientific issues associated with genetic testing abound.
Last week, we witnessed a major step toward reigning in what has, until last year, been a veritable Wild West of genetic testing. On Monday, a U.S. District Court Judge in Utah decided that Myriad Genetics could not stop a competitor (Ambry Genetics) from offering commercial BRCA ("breast cancer gene") testing as their current legal suit winds through the courts. (Full disclosure: Breast Cancer Action filed an amicus brief in opposition to Myriad's request for an injunction, along with the American Civil Liberties Union (ACLU), Public Patent Foundation (PUBPAT), Association for Molecular Pathology (AMP), and the AARP, each of which was also involved in a multi-year lawsuit cited below which challenged Myriad's patent claims on the two BRCA genes.)
This somewhat esoteric legal...
Related Articles
By Megan Agnew, The Times | 09.15.2024
Faith Hartley always wanted two girls — a blonde and a redhead. “I thought, I’ll have one that looks like me,” says Hartley, 35, smoothing her golden hair in the Los Angeles valley home she shares with her husband, Neil...
By Emily R. Klancher Merchant, Los Angeles Review of Books | 08.22.2024
IN THE Operation Varsity Blues scandal of 2019, 50 wealthy parents were charged with trying to get their children into elite universities through fraudulent means. The story dramatically demonstrated the lengths to which some parents will go to ensure their...
By Julia Brown, The Conversation | 08.16.2024
With their primary goal to advance scientific knowledge, most scientists are not trained or incentivized to think through the societal implications of the technologies they are developing. Even in genomic medicine, which is geared toward benefiting future patients, time and...
By Smriti Mallapaty, Nature | 09.11.2024
Under his microscope, Jun Wu could see several tiny spheres, each less than 1 millimetre wide. They looked just like human embryos: a dark cluster of cells surrounded by a cavity, and then another ring of cells.
But Wu, a...